01.02.2015
Specific Anti-IIa Activity is a Key Indicator of Safety and Efficacy in Validation of Biosimilarity of Unfractioned Heparin Preparations
Erschienen in: Bulletin of Experimental Biology and Medicine | Ausgabe 4/2015
Einloggen, um Zugang zu erhalten